InvestSMART

Mesoblast Limited (ASX: MSB) - Announcements

Current share price for MSB : $2.715 0.125 (4.83%)+

ASX company news and announcements for Mesoblast Limited (MSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mesoblast Limited (MSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mesoblast Limited (MSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mesoblast Limited (MSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3,534 Notification regarding unquoted securities - MSB 13 Jan 2026 7:15PM $2.730 $2.730 fallen by 0%
$3,534 Application for quotation of securities - MSB 13 Jan 2026 7:06PM $2.730 $2.730 fallen by 0%
$3,534 Appendix 3Y for Eric Rose 13 Jan 2026 6:58PM $2.730 $2.730 fallen by 0%
$3,534 Appendix 3Y for Lyn Cobley 12 Jan 2026 9:52AM $3.070 $2.730 fallen by 11.07%
$3,534 Ryoncil Sales for the Quarter Increase 60% to US$35.1M 9 Jan 2026 9:57AM $2.950 $2.730 fallen by 7.46%
$3,534 Appendix 3Y for Gregory George 6 Jan 2026 6:31PM $2.740 $2.730 fallen by 0.36%
$3,534 Notification of cessation of securities - MSB 6 Jan 2026 6:18PM $2.740 $2.730 fallen by 0.36%
$3,534 Mesoblast Announces Changes to Board of Director Roles 2 Jan 2026 9:38AM $2.720 $2.730 risen by 0.37%
$3,534 Release of Shares from Voluntary Escrow 30 Dec 2025 4:19PM $2.800 $2.730 fallen by 2.50%
$3,534 Proposed issue of securities - MSB 30 Dec 2025 10:21AM $2.900 $2.730 fallen by 5.86%
$3,534 Mesoblast Enters into Non-Dilutive Lower Cost 5-Year Credit 30 Dec 2025 10:02AM $2.840 $2.730 fallen by 3.87%
$3,534 Appendix 3Y for Gregory George 23 Dec 2025 5:30PM $2.880 $2.730 fallen by 5.21%
$3,534 Ceasing to be a substantial holder 19 Dec 2025 8:17AM $2.800 $2.730 fallen by 2.50%
$3,534 Notification regarding unquoted securities - MSB 17 Dec 2025 6:47PM $2.800 $2.730 fallen by 2.50%
$3,534 Becoming a substantial holder 17 Dec 2025 8:22AM $2.770 $2.730 fallen by 1.44%
$3,534 Warrant Prospectus Related to Convertible Note Agreements 16 Dec 2025 7:52PM $2.770 $2.730 fallen by 1.44%
$3,534 Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD 12 Dec 2025 10:02AM $2.785 $2.730 fallen by 1.97%
$3,534 Ceasing to be a substantial holder 10 Dec 2025 8:17PM $2.870 $2.730 fallen by 4.88%
$3,534 Becoming a substantial holder 9 Dec 2025 5:57PM $2.820 $2.730 fallen by 3.19%
$3,534 Mesoblast Participation at Piper Sandler Conference 4 Dec 2025 9:52AM $2.520 $2.730 risen by 8.33%
$3,534 Ceasing to be a substantial holder 27 Nov 2025 6:32PM $2.690 $2.730 risen by 1.49%
$3,534 Results of Meeting 25 Nov 2025 2:32PM $2.365 $2.730 risen by 15.43%
$3,534 Ryoncil Revenue Growth Highlighted in AGM Trading Update 25 Nov 2025 10:00AM $2.330 $2.730 risen by 17.17%
$3,534 CEO Presentation to 2025 Annual General Meeting 25 Nov 2025 9:52AM $2.330 $2.730 risen by 17.17%
$3,534 Mesoblast Chair Message to 2025 AGM 25 Nov 2025 9:49AM $2.330 $2.730 risen by 17.17%

51 - 75 of 1167 results

Page 3 of 47

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.